MIRCERA.com

MIRCERA® provides efficiencies to healthcare professionals, support staff and patients. Haemoglobin levels can be successfully maintained by using once-monthly MIRCERA; that is only 12 injections per year. MIRCERA requires fewer injections per year than other erythropoiesis-stimulating agents (ESAs) (see Figure).^1–3 This results in a reduced risk of needlestick injuries and enables staff to devote more time to other patient needs.

 

 

Number of injections per year with once-monthly MIRCERA, epoetin three times per week or darbepoetin alfa or epoetin once per week.

 

Refrigeration of MIRCERA is not required for a single period of up to 1 month, so the risk of lost or discarded product is reduced if there is ever an interruption in refrigeration. Other ESAs have a much shorter shelf-life at room temperature than MIRCERA (see Figure).^1–4

 

 

Shelf-life of MIRCERA at room temperature compared with other ESAs.^1–4

 

Storage information
MIRCERA should be stored at 2–8^oC and kept it in the original packaging to protect it from light. MIRCERA may be removed from the refrigerator for storage at room temperature (not above 25^oC) for one single period of up to 1 month. Once removed from the refrigerator, MIRCERA must be used within 1 month. MIRCERA should be allowed to reach room temperature before injecting.

 

References:

 

1. Aranesp® Summary of Product Characteristics. Amgen. 2006.
2. MIRCERA® Summary of Product Characteristics. F. Hoffmann-La Roche Ltd. 2007.
3. Eprex® Summary of Product Characteristics. Janssen-Cilag Ltd. 2006.
4. NeoRecormon® Summary of Product Characteristics. F. Hoffmann-La Roche Ltd. 2007.